Arizona bats test positive for possibly deadly fungus; wildlife agency seeks public's help
A bat that was part of the cave myotis species in Fort Huachuca, just west of Sierra Vista, tested positive for a fungus known as Pseudogymnoascus destructans (Pd) that can cause deadly white-nose syndrome (WNS), according to the Arizona Department of Game and Fish.
The positive sample was collected during a June 2024 surveillance when Game and Fish identified a bat with abnormal wing features linked to the disease. The agency later discovered four additional bats, including two from other species, that tested positive for trace amounts of the fungus.
Debbie Brewer, a Game and Fish biologist for the Fort Huachuca area, said monitoring for the Pd has existed in the area since 2014, with positive infections found in 2017, followed by low-level spread in 2021 and 2023.
"Though not unexpected, our 2024 high-level positive detection in cave myotis is highly concerning and should put other land managers in the Southwest on alert that habitat protections for this and other species of bat are warranted," wrote Brewer in a news release.
With the help of citizen scientists: An endangered bat species has been found in Arizona
Pd, which causes white-nose syndrome, is named after the white fungal growth seen on infected bats. Since 2006, the disease has led to the deaths of millions of bats across 40 U.S. states and nine Canadian provinces, according to Game and Fish.
White-nose syndrome does not pose a risk to humans or pets, but human activity is a major concern for bringing fungal spores into cold, humid caves where bats hibernate, and where optimal growing conditions exist for the fungus.
'This disease did not exist when I first began working with bats. To see new threats to our bat populations like this is disturbing," said Angie McIntire, a specialist on Arizona bats for Game and Fish.
A bat infected with WNS may display unusual behavior, which Game and Fish said usually appears like the bat is unable to fly or is perched low on a wall or is on the ground.
The wildlife agency asks the public to help monitor for the disease by reporting any possible cases by email to bats@azgfd.gov, sending a detailed report of the encounter, photos, location and contact information, but also reminds the public to never handle bats.
Game and Fish said since 2019, the fungus has been found in Mohave, Coconino, Yavapai and Cochise counties, and at Grand Canyon National Park. Between 2021 and 2024, a total of eight bats, including cave myotis, southwestern myotis and big brown bats, tested positive for the fungus.
Infections within the cave myotis bat species also have been found nearby in New Mexico and Texas, highlighting to researchers a possible vulnerability among the species for WNS.
Bat season in Arizona: What attracts them and are they dangerous?
Reach reporter Rey Covarrubias Jr. at rcovarrubias@gannett.com. Follow him on X, Threads and Bluesky @ReyCJrAZ.
This article originally appeared on Arizona Republic: Bats in southern Arizona test positive for fungus deadly to species
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
4 hours ago
- Business Upturn
EndoDiagnosis & ENDOSURE Revolutionize Endometriosis Detection in Canada with 30-Minute Non-Invasive Test
Kelowna, Aug. 04, 2025 (GLOBE NEWSWIRE) — EndoDiagnosis is changing the landscape of women's healthcare with its new role as the sole distributor in Canada for the ENDOSURE Tier 1 diagnostic test for endometriosis. This new diagnostic tool marks a significant shift in how endometriosis is detected and managed, cutting down the average diagnosis time from over eight years to just 30 minutes. In the past, diagnosing endometriosis required invasive laparoscopic surgery. This often meant that patients endured years of pain and a lower quality of life without a proper diagnosis. The ENDOSURE test offers a non-invasive option, boasting 99% accuracy in detecting all stages of the disease in less than an hour. This bypasses the need for surgical procedures. Learn more about EndoDiagnosis and what they offer by visiting their website. This development is crucial for addressing a major gap in healthcare. Women suffering from endometriosis symptoms frequently face challenges in receiving the correct diagnosis and treatment. By providing a quick and effective diagnostic tool, ENDOSURE helps healthcare providers make faster, more informed decisions, improving care for those impacted by this chronic illness. Maria Porcellato, CEO of EndoDiagnosis, stated, 'We have seen the desperation in patients, clients, and even our own daughters that comes with undiagnosed endometriosis. Our mission centers on empowering both patients and healthcare teams with the decision-support tools they need to make informed decisions about healthcare.' The ENDOSURE Tier 1 test is designed for women of any age and provides results on the spot without the need for referrals or lab work. Its non-invasive nature not only spares patients from unnecessary surgical procedures but also enables healthcare professionals to concentrate on therapeutic strategies to manage the disease, preserving both quality of life and fertility. EndoDiagnosis is not just distributing this advanced technology but is also dedicated to ensuring its successful use in clinics throughout Canada. The company offers training and certification for healthcare providers, professional medical education, and awareness programs, along with a provider directory to help patients find testing centers. This initiative places Canada at the forefront of endometriosis care, allowing healthcare professionals to offer their patients both clarity and hope. Carolyn Plican, COO of EndoDiagnosis, stressed the importance of this development, commenting, 'This partnership represents more than a business agreement – it's about validating women's experiences and providing the answers they desperately need. When patients understand the root cause of their symptoms, it reduces stress, creates closure, and empowers them to move forward with effective treatment strategies.' The ENDOSURE test is ready for immediate use by Canadian clinicians. Healthcare providers interested in adopting this test can contact EndoDiagnosis for details about installation, training, and certification opportunities. To further support education and awareness, EndoDiagnosis has launched the 'Endometriosis A to Z' podcast, which addresses all ages and stages of the disease, aiming to educate and empower its audience. Through this comprehensive resource, individuals can stay informed about endometriosis and its management. EndoDiagnosis Inc. stands as the exclusive Canadian distributor of ENDOSURE, a non-invasive diagnostic test authorized by Health Canada that aids in the faster and more accurate diagnosis of endometriosis. Guided by a team of physicians and pharmacists, EndoDiagnosis is devoted to advancing women's health through innovative, science-based diagnostics and restorative reproductive care. ### For more information about EndoDiagnosis Inc., contact the company here: EndoDiagnosis Plican1-833-439-3636 [email protected] 6903 142 Ave NW, Edmonton, AB T5C 2P1


New York Post
7 hours ago
- New York Post
Canadian wildfires spark NY air-quality alert: ‘Can pose serious health risks'
Canadian wildfires may be posing 'serious health risks'' to people in New York — prompting an air-quality alert for the state through Monday and a warning for some regions into Tuesday. The metro area's current ailing air quality and hazy skies are hampering the five boroughs, Long Island, Hudson Valley, Adirondacks, eastern Lake Ontario and Central and Western New York regions, according to an alert issued Monday by Gov. Kathy Hochul. Canadian wildfires cloak Manhattan in haze last month. Luiz C. Ribeiro for New York Post Advertisement Pollution from fine particulate matter fueled by the wildfires is expected to push the local Air Quality Index past 100, meaning it will be unhealthy for sensitive groups, including children, older adults and people with heart or lung conditions. In some areas, the index could go above 150 momentarily. The tiny particles can cause eye, nose, and throat irritation along with coughing, sneezing and shortness of breath. They can also worsen asthma and heart disease. Advertisement 'New York continues to track air quality conditions across the state, and people in certain areas may notice visible smoke throughout the day,' Hochul said in a statement. The advisory remains in effect through 11:59 p.m. Monday, but weather patterns are anticipated to bring more spikes in smoke in certain regions across the state Tuesday. Wildfires destroy scores of acres in British Columbia. AP Officials urged everyone in sensitive groups to check their local Air Quality Index and take precautions, including limiting outdoor activity. Advertisement 'Poor air quality can pose serious health risks — especially for those with heart conditions, lung diseases, such as asthma, young children, those over 65 years old, and pregnant individuals,' New York Health Commissioner Dr. James McDonald said in a statement. 'To reduce exposure, limit strenuous activity outdoors.' The smoky situation is just the latest to cloud city skies this year. Multiple alerts were issued in June when ozone pollution and wildfire haze from Canada triggered warnings across the tri-state area. Advertisement More than 700 active wildfires are currently blazing across Canada, with roughly two-thirds of them still out of control, according to the Canadian Interagency Forest Fire Center.


UPI
12 hours ago
- UPI
Multiple sclerosis could affect health years before classic symptoms
New research from Canada's University of British Columbia found patients diagnosed with multiple sclerosis started to experience new health issues up to 15 years before showing the classic symptoms of the condition. Photo by Adobe Stock/HealthDay Aug. 4 (UPI) -- People with multiple sclerosis, or MS, begin experiencing new health issues up to 15 years before the classic signs of the illness appear, Canadian research shows. "MS can be difficult to recognize as many of the earliest signs -- like fatigue, headache, pain and mental health concerns -- can be quite general and easily mistaken for other conditions," study senior author Helen Tremlett noted. "Our findings dramatically shift the timeline for when these early warning signs are thought to begin, potentially opening the door to opportunities for earlier detection and intervention," said Tremlett, a professor of neurology at the University of British Columbia in Vancouver. Her team published its findings Friday in JAMA Network Open. MS is an autoimmune illness in which the body's immune system goes awry, attacking the protective myelin sheath that surrounds nerves within the brain and along the spinal cord. Communication breaks down between the brain and the body, leading to progressive disability. The new study that suggests MS may begin more than a decade before a clinical diagnosis. Tremlett's group combed through British Columbia health data for 12,000 people with or without MS. Records went back as far as 25 years prior to an MS patient's diagnosis. That's far longer than the five to 10 years covered in earlier studies looking at disease onset. The main findings: Fifteen years before the onset of classic MS symptoms, there was a noticeable uptick in patient visits to their general practitioner, or in visits to specialists for issues like fatigue, pain and dizziness, as well as mental health issues such as anxiety and depression. Twelve years before symptom onset, visits to psychiatrists began to rise. Eight to nine years before, visits to neurologists and eye specialists rose, perhaps linked to issues such as blurred vision or eye pain. Three to five years before, researchers noted a rise in visits to emergency departments and/or radiology facilities. One year before, visits peaked for a wide range of different physician types, such as neurologists, radiologists and emergency doctors. "These patterns suggest that MS has a long and complex prodromal phase -- where something is happening beneath the surface but hasn't yet declared itself as MS," said study first author Dr. Marta Ruiz-Algueró, a postdoctoral fellow at UBC. "We're only now starting to understand what these early warning signs are, with mental health-related issues appearing to be among the earliest indicators," she added in a news release. The researchers stressed that the early issues that drove MS patients to seek out care can be caused by a myriad of health conditions. Simply experiencing these conditions does not mean a person will go on to develop MS. Nevertheless, "By identifying these earlier red flags, we may eventually be able to intervene sooner -- whether that's through monitoring, support or preventive strategies," Tremlett said a university news release. "It opens new avenues for research into early biomarkers, lifestyle factors and other potential triggers that may be at play during this previously overlooked phase of the disease." More information Find out more about multiple sclerosis at the National Multiple Sclerosis Society Copyright © 2025 HealthDay. All rights reserved.